| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy
|
O’Leary, Valerie B.
|
|
2018
|
15 |
2 |
p. 489-499
|
artikel
|
| 2 |
Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy
|
O'Leary, Valerie B.
|
|
|
15 |
2 |
p. 489-499
|
artikel
|
| 3 |
Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in Taiwan
|
Tzeng, Nian-Sheng
|
|
2018
|
15 |
2 |
p. 417-429
|
artikel
|
| 4 |
Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in Taiwan
|
Tzeng, Nian-Sheng
|
|
|
15 |
2 |
p. 417-429
|
artikel
|
| 5 |
Association of Herpes Viral Infections, Antiherpetic Therapy, and Dementia: Real or Alternative Fact?
|
Nath, Avindra
|
|
2018
|
15 |
2 |
p. 415-416
|
artikel
|
| 6 |
Association of Herpes Viral Infections, Antiherpetic Therapy, and Dementia: Real or Alternative Fact?
|
Nath, Avindra
|
|
|
15 |
2 |
p. 415-416
|
artikel
|
| 7 |
Brain Renin–Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity
|
Jiang, Linhong
|
|
2018
|
15 |
2 |
p. 500-510
|
artikel
|
| 8 |
Brain Renin–Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity
|
Jiang, Linhong
|
|
|
15 |
2 |
p. 500-510
|
artikel
|
| 9 |
Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson’s Disease
|
Navarrete, Francisco
|
|
2018
|
15 |
2 |
p. 459-469
|
artikel
|
| 10 |
Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease
|
Navarrete, Francisco
|
|
|
15 |
2 |
p. 459-469
|
artikel
|
| 11 |
Correction to: Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action
|
Ong, Jonathan Jia Yuan
|
|
2018
|
15 |
2 |
p. 525-526
|
artikel
|
| 12 |
Correction to: Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action
|
Ong, Jonathan Jia Yuan
|
|
|
15 |
2 |
p. 525-526
|
artikel
|
| 13 |
Correction to: Neuroimmune Response in Ischemic Preconditioning
|
McDonough, Ashley
|
|
2017
|
15 |
2 |
p. 511-524
|
artikel
|
| 14 |
Correction to: Neuroimmune Response in Ischemic Preconditioning
|
McDonough, Ashley
|
|
|
15 |
2 |
p. 511-524
|
artikel
|
| 15 |
Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action
|
Sprenger, Till
|
|
2018
|
15 |
2 |
p. 313-323
|
artikel
|
| 16 |
Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action
|
Sprenger, Till
|
|
|
15 |
2 |
p. 313-323
|
artikel
|
| 17 |
Glutamate and Its Receptors as Therapeutic Targets for Migraine
|
Hoffmann, Jan
|
|
2018
|
15 |
2 |
p. 361-370
|
artikel
|
| 18 |
Glutamate and Its Receptors as Therapeutic Targets for Migraine
|
Hoffmann, Jan
|
|
|
15 |
2 |
p. 361-370
|
artikel
|
| 19 |
Intrinsic Inflammation Is a Potential Anti-Epileptogenic Target in the Organotypic Hippocampal Slice Model
|
Chong, Seon-Ah
|
|
2018
|
15 |
2 |
p. 470-488
|
artikel
|
| 20 |
Intrinsic Inflammation Is a Potential Anti-Epileptogenic Target in the Organotypic Hippocampal Slice Model
|
Chong, Seon-Ah
|
|
|
15 |
2 |
p. 470-488
|
artikel
|
| 21 |
Migraine Therapy: Current Approaches and New Horizons
|
Goadsby, Peter J.
|
|
2018
|
15 |
2 |
p. 271-273
|
artikel
|
| 22 |
Migraine Therapy: Current Approaches and New Horizons
|
Goadsby, Peter J.
|
|
|
15 |
2 |
p. 271-273
|
artikel
|
| 23 |
Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action
|
Ong, Jonathan Jia Yuan
|
|
2017
|
15 |
2 |
p. 274-290
|
artikel
|
| 24 |
Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action
|
Ong, Jonathan Jia Yuan
|
|
|
15 |
2 |
p. 274-290
|
artikel
|
| 25 |
Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy—a Prospective Follow-Up
|
Härtig, Florian
|
|
2018
|
15 |
2 |
p. 439-451
|
artikel
|
| 26 |
Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy—a Prospective Follow-Up
|
Härtig, Florian
|
|
|
15 |
2 |
p. 439-451
|
artikel
|
| 27 |
Non-Pharmacological Approaches for Migraine
|
Puledda, Francesca
|
|
2018
|
15 |
2 |
p. 336-345
|
artikel
|
| 28 |
Non-Pharmacological Approaches for Migraine
|
Puledda, Francesca
|
|
|
15 |
2 |
p. 336-345
|
artikel
|
| 29 |
Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia
|
Scorr, Laura M.
|
|
2018
|
15 |
2 |
p. 452-458
|
artikel
|
| 30 |
Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia
|
Scorr, Laura M.
|
|
|
15 |
2 |
p. 452-458
|
artikel
|
| 31 |
Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial
|
Ahmadi, Mona
|
|
2018
|
15 |
2 |
p. 430-438
|
artikel
|
| 32 |
Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial
|
Ahmadi, Mona
|
|
|
15 |
2 |
p. 430-438
|
artikel
|
| 33 |
Targeted Acid-Sensing Ion Channel Therapies for Migraine
|
Karsan, Nazia
|
|
2018
|
15 |
2 |
p. 402-414
|
artikel
|
| 34 |
Targeted Acid-Sensing Ion Channel Therapies for Migraine
|
Karsan, Nazia
|
|
|
15 |
2 |
p. 402-414
|
artikel
|
| 35 |
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
|
Holland, Philip R.
|
|
2018
|
15 |
2 |
p. 304-312
|
artikel
|
| 36 |
Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy
|
Holland, Philip R.
|
|
|
15 |
2 |
p. 304-312
|
artikel
|
| 37 |
Targeted 5-HT1F Therapies for Migraine
|
Vila-Pueyo, Marta
|
|
2018
|
15 |
2 |
p. 291-303
|
artikel
|
| 38 |
Targeted 5-HT1F Therapies for Migraine
|
Vila-Pueyo, Marta
|
|
|
15 |
2 |
p. 291-303
|
artikel
|
| 39 |
Targeted Nitric Oxide Synthase Inhibitors for Migraine
|
Pradhan, Amynah A.
|
|
2018
|
15 |
2 |
p. 391-401
|
artikel
|
| 40 |
Targeted Nitric Oxide Synthase Inhibitors for Migraine
|
Pradhan, Amynah A.
|
|
|
15 |
2 |
p. 391-401
|
artikel
|
| 41 |
Targeted Orexin and Hypothalamic Neuropeptides for Migraine
|
Strother, Lauren C.
|
|
2018
|
15 |
2 |
p. 377-390
|
artikel
|
| 42 |
Targeted Orexin and Hypothalamic Neuropeptides for Migraine
|
Strother, Lauren C.
|
|
|
15 |
2 |
p. 377-390
|
artikel
|
| 43 |
Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine
|
Vollesen, Anne Luise Haulund
|
|
2018
|
15 |
2 |
p. 371-376
|
artikel
|
| 44 |
Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine
|
Vollesen, Anne Luise Haulund
|
|
|
15 |
2 |
p. 371-376
|
artikel
|
| 45 |
The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
|
Raffaelli, Bianca
|
|
2018
|
15 |
2 |
p. 324-335
|
artikel
|
| 46 |
The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
|
Raffaelli, Bianca
|
|
|
15 |
2 |
p. 324-335
|
artikel
|
| 47 |
Therapeutic Approaches for the Management of Trigeminal Autonomic Cephalalgias
|
Wei, Diana Y.
|
|
2018
|
15 |
2 |
p. 346-360
|
artikel
|
| 48 |
Therapeutic Approaches for the Management of Trigeminal Autonomic Cephalalgias
|
Wei, Diana Y.
|
|
|
15 |
2 |
p. 346-360
|
artikel
|
Tijdschrift beschrijving